OpGen, Inc. Announces $10 Million Private Placement Priced at the Market
GAITHERSBURG, Md., Nov. 24, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power...
Year: 2020
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy
HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in...
Mustang Bio Announces Positive Opinion from the European Medicines Agency on Orphan Drug Designation for Its Lentiviral Gene Therapy for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)
WORCESTER, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib
Trial enrolled patients ahead of originally anticipated timeline despite COVID-19 pandemic SOUTH SAN FRANCISCO, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE)...
American Academy of Home Care Medicine Partners with Tabula Rasa HealthCare to Offer Online Clinical Documentation Education for Members
MOORESTOWN, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing...
Centro Rossi Implements Konica Minolta Healthcare’s Exa Platform Across Multiple Centers in Argentina
WAYNE, N.J., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. announces that Centro Rossi, a leading healthcare...
Fulgent Genetics to Participate in the Piper Sandler 32nd Annual Healthcare Conference
TEMPLE CITY, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a...
Applied Molecular Transport to Present at Evercore ISI 3rd Annual HealthCONx Conference
SOUTH SAN FRANCISCO, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical...
Oculis to Present Progress in its Portfolio of Novel Topical Treatments for Retinal and Front-of-the-Eye Diseases at Upcoming Investor Conferences
LAUSANNE, Switzerland, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Oculis S.A., a biopharmaceutical company focused on developing transformative topical ophthalmic treatments...
89bio To Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
SAN FRANCISCO, Nov. 24, 2020 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development...
CRISPR Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on...
Jushi Holdings Inc. Reports Third Quarter 2020 Financial Results
Third Quarter 2020 Revenue Increases 67% Sequentially to $24.9 million; Gross Profit Increases 64% Sequentially to $12.3 million; Increases Fourth...
iCAD Reports Over 1,000 Licenses Sold as Part of ProFound AI Sales
Significant Percentage of Licenses Sold to Facilities with GE, Siemens, and Sites with Multiple Vendors Including Hologic and Fuji ProFound...
Auxly Announces $10 Million Bought-Deal Public Offering
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 24, 2020 (GLOBE NEWSWIRE) --...
Black Diamond Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology...
Olainfarm invites to Third Quarter 2020 Investor Conference Webinar
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on December...
Strongbridge Biopharma plc Announces Publication of Secondary Endpoints Data from Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome in the Journal, Pituitary
~ RECORLEV™ (levoketoconazole) Treatment Resulted in Significantly Improved Clinician-Assessed Signs and Symptoms and Patient-Reported Outcomes of Cushing’s Syndrome ~ DUBLIN,...
Kura Oncology to Host Virtual Investor Event on December 5, 2020
Event to follow presentation of preliminary clinical data for menin inhibitor KO-539 at ASH SAN DIEGO, Nov. 24, 2020 (GLOBE...
Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference
BOSTON and LONDON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced...
Capricor Therapeutics Commences Dosing Patients in Phase 2 Trial of CAP-1002 in Patients with Severe COVID-19
- Data Expected Second Quarter 2021 - - The INSPIRE Trial Is Designed to Assess the Ability of CAP-1002 to...